{
  "@type": "NewsArticle",
  "identifier": "2022--03--05--en--myfeed--HackerNews--NewsArticle--30570662",
  "url": "https://news.ycombinator.com/item?id=30570662",
  "headline": "AI Driven Drug Goes to Phase 1 Clinical Trials",
  "publisher": {
    "@type": "Organization",
    "name": "HackerNews",
    "url": "https://news.ycombinator.com",
    "logo": "https://hn.buzzing.cc/avatar.png"
  },
  "description": "",
  "keywords": [],
  "author": {
    "@type": "Person",
    "name": "oxmane",
    "url": "https://news.ycombinator.com/user?id=oxmane"
  },
  "discussionUrl": "https://news.ycombinator.com/item?id=30570662",
  "sameAs": "https://www.prnewswire.com/in/news-releases/insilico-announces-successful-completion-of-phase-0-microdose-trial-and-initiates-phase-i-clinical-trial-for-its-first-ai-discovered-anti-fibrotic-product-candidate-with-novel-target-884919950.html",
  "dateCreated": "2022-03-05T19:09:15.103Z",
  "datePublished": "2022-03-05T18:56:05.000Z",
  "dateModified": "2022-03-05T19:09:15.103Z",
  "interactionStatistic": [
    {
      "@type": "InteractionCounter",
      "interactionType": {
        "@type": "LikeAction"
      },
      "userInteractionCount": 1
    },
    {
      "@type": "InteractionCounter",
      "interactionType": {
        "@type": "CommentAction"
      },
      "userInteractionCount": 0
    }
  ],
  "headline_zh-Hans": "人工智能驱动的药物进入1期临床试验阶段",
  "headline_zh-Hant": "人工智能驅動的藥物進入1期臨床試驗階段",
  "@context": [
    "https://schema.org",
    {
      "@vocab": "http://schema.org/",
      "@language": "en",
      "headline_zh-Hans": {
        "@id": "headline",
        "@language": "zh-Hans"
      },
      "headline_zh-Hant": {
        "@id": "headline",
        "@language": "zh-Hant"
      },
      "@version": 1.1
    }
  ]
}